Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
31.10.25
/
50%
€167.00
Target price
31.10.26
-
Performance (%)
-2.99%
Price
07:36
?
Summary
This prediction is currently active. With a performance of -2.99%, the BUY prediction by The_Goldman_Sachs_Gr is trending in the wrong direction. This prediction currently runs until 31.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Insmed Inc. | -2.99% |
| iShares Core DAX® | -0.710% |
| iShares Nasdaq 100 | 1.556% |
| iShares Nikkei 225® | 4.150% |
| iShares S&P 500 | 0.738% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for INSM provided by MarketBeat

